Effectiveness of rotavirus vaccine in preventing severe gastroenteritis in young children according to socioeconomic status
Authors:
Open Access
- 13 June 2016
- journal article
- research article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 12 (10) , 2572-2579
Abstract
In 2011, the monovalent rotavirus vaccine was introduced into a universal immunization program in Quebec (Canada). This retrospective cohort study assessed vaccine effectiveness (VE) in preventing acute gastroenteritis (AGE) and rotavirus gastroenteritis (RVGE) hospitalizations among children <3 y living in the Quebec Eastern Townships region according to socioeconomic status (SES). Data were gathered from a tertiary hospital database paired with a regional immunization registry. Three cohorts of children were followed: (1) vaccinated children born in post-universal vaccination period (2011–2013, n = 5,033), (2) unvaccinated children born in post-universal vaccination period (n = 1,239), and (3) unvaccinated children born in pre-universal vaccination period (2008–2010, n = 6,436). In each cohort, AGE and RVGE hospitalizations were identified during equivalent follow-up periods to calculate VE globally and according to neighborhood-level SES. Using multivariable logistic regression, adjusted odds ratios (OR) were computed to obtain VE (1-OR). Adjusted VE of 2 doses was 62% (95% confidence interval [CI]: 37%–77%) and 94% (95%CI: 52%–99%) in preventing AGE and RVGE hospitalization, respectively. Stratified analyses according to SES showed that children living in neighborhoods with higher rates of low-income families had significantly lower VE against AGE hospitalizations compared to neighborhoods with lower rates of low-income families (30% vs. 78%, p = 0.027). Our results suggest that the rotavirus vaccine is highly effective in preventing severe gastroenteritis in young children, particularly among the most well-off. SES seems to influence rotavirus VE, even in a high-income country like Canada. Further studies are needed to determine factors related to lower rotavirus VE among socioeconomically disadvantaged groups.Keywords
This publication has 35 references indexed in Scilit:
- Impact of rotavirus vaccination on hospitalizations for rotavirus diarrhea: The IVANHOE studyVaccine, 2011
- Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in AustriaVaccine, 2011
- Effectiveness of the Pentavalent Rotavirus Vaccine in Preventing Gastroenteritis in the United StatesPediatrics, 2010
- Effectiveness of Pentavalent Rotavirus Vaccine in a Large Urban Population in the United StatesPediatrics, 2010
- Oral Rotavirus Vaccines: How Well Will They Work Where They Are Needed Most?The Journal of Infectious Diseases, 2009
- Secular Variation in United States Rotavirus Disease Rates and SerotypesThe Pediatric Infectious Disease Journal, 2009
- Association Between Pentavalent Rotavirus Vaccine and Severe Rotavirus Diarrhea Among Children in NicaraguaJAMA, 2009
- Routine Laboratory Testing Data for Surveillance of Rotavirus Hospitalizations to Evaluate the Impact of VaccinationThe Pediatric Infectious Disease Journal, 2007
- Rotavirus immunoglobulin levels among Indian mothers of two socio‐economic groups and occurrence of rotavirus infections among their infants up to six monthsJournal of Medical Virology, 2007
- Hospitalisations for gastroenteritis: the role of rotavirusVaccine, 2004